Suppr超能文献

纤维蛋白原-白蛋白比值与肌肉减少症联合预测行根治性手术的喉癌患者预后的意义研究。

Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.

机构信息

Department of Otolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, 362000, China.

Department of Ophthalmology, Shaowu Municipal Hospital of Fujian Province, Shaowu, Nanping, Fujian, 354000, China.

出版信息

BMC Cancer. 2024 Oct 11;24(1):1265. doi: 10.1186/s12885-024-13039-2.

Abstract

OBJECTIVE

This study aims to investigate how the impact of preoperative sarcopenia and inflammatory markers for laryngeal cancer patients and develop a new scoring system to predict their prognosis.

MATERIALS AND METHODS

Patients who underwent laryngectomy for laryngeal cancer (LC) from December 2015 to December 2020 at the Second Affiliated Hospital of Fujian Medical University were included. Independent prognostic factors were determined using univariate and multivariate analyses. A new scoring system (SFAR) was established based on FAR and preoperative sarcopenia, and statistically analyzed.

RESULTS

198 cases included in this study that met the admission criteria. Multivariate analysis shown that preoperative sarcopenia, pTNM stage, and FAR were independent prognostic factors for laryngeal cancer. Based on these three indicators, we developed the SFAR scoring system. Multivariate analysis showed that SFAR was an independent predictor of laryngeal cancer (p < 0.001). SFAR was then incorporated into a prognostic model that included T-stage and N-stage, and a column-line graph was generated to accurately predict its survival.

CONCLUSION

Systemic inflammation and sarcopenia are significantly associated with postoperative prognosis in laryngeal cancer. A new scoring system (SFAR) had implications for improving the prognosis of patients undergoing surgery for laryngeal cancer.

摘要

目的

本研究旨在探讨术前肌少症和炎症标志物对喉癌患者的影响,并建立新的评分系统来预测其预后。

材料与方法

纳入 2015 年 12 月至 2020 年 12 月在福建医科大学附属第二医院行喉切除术的喉癌(LC)患者。采用单因素和多因素分析确定独立预后因素。基于 FAR 和术前肌少症建立新的评分系统(SFAR),并进行统计学分析。

结果

本研究共纳入 198 例符合纳入标准的患者。多因素分析显示,术前肌少症、pTNM 分期和 FAR 是喉癌的独立预后因素。基于这三个指标,我们开发了 SFAR 评分系统。多因素分析显示 SFAR 是喉癌的独立预测因素(p<0.001)。SFAR 随后被纳入包含 T 分期和 N 分期的预后模型,并生成列线图以准确预测其生存情况。

结论

全身炎症和肌少症与喉癌术后预后显著相关。新的评分系统(SFAR)有助于改善接受喉癌手术治疗患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f1/11468157/32e0c30e916f/12885_2024_13039_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验